Taiwan FDA registration eebc2ba9d42c250fab6e28ee32bfceb1
"Tsaiwei" Ovixun Aix abdominal artificial vascular stent system
TW: “采葳科”歐維迅艾克斯腹部人工血管覆膜支架系統
Taiwan·Risk Class 3·TriVascular, Inc.·Registered Dec 16, 2019 – Dec 16, 2024CancelledRegistration details
- Analysis ID
- eebc2ba9d42c250fab6e28ee32bfceb1
- Customs Code
- DHA05603162006
Company information
- Manufacturer
- TriVascular, Inc.
- Manufacturer Country
- United States
- Authorized Representative
- GETZ BROS & CO. (BVI), INC., TAIWAN BRANCH
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- E Cardiovascular Medicine Science
- Product Type (Level 2)
- E.0006.
- Import Information
- The use of this device shall comply with the provisions of the "Administrative Measures for the Implementation or Use of Medical Devices for Specific Medical Technology Inspection and Testing". input
Dates and status
- Registration Date
- Dec 16, 2019
- Expiry Date
- Dec 16, 2024
- Cancellation Date
- Dec 25, 2020
Cancellation information
- Status
- Logged out
- Reason
- 自請註銷
About this record
Access comprehensive regulatory information for "Tsaiwei" Ovixun Aix abdominal artificial vascular stent system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number eebc2ba9d42c250fab6e28ee32bfceb1 and manufactured by TriVascular, Inc.. The authorized representative in Taiwan is GETZ BROS & CO. (BVI), INC., TAIWAN BRANCH.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices